These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 30194738)

  • 1. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
    Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple myeloma and chemical maxillary osteonecrosis. Can both occur simultaneously?
    Junquera S; Álvarez-Yagüe E; Junquera L; Ugalde R; Rúa L
    J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):523-526. PubMed ID: 31863926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
    Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
    J Formos Med Assoc; 2021 Aug; 120(8):1572-1580. PubMed ID: 33309430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dental pathologies in tumor patients with bone metastases or multiple myeloma scheduled for antiresorptive therapy.
    Laimer J; Hechenberger M; Müller D; Walch B; Kolk A; Schnabl D; Schomaker M; Bruckmoser E
    Future Oncol; 2021 Jul; 17(21):2705-2711. PubMed ID: 33880956
    [No Abstract]   [Full Text] [Related]  

  • 6. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates.
    Sobczak-Jaskow H; Kochańska B; Drogoszewska B
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374277
    [No Abstract]   [Full Text] [Related]  

  • 8. The Incidence and Severity of Medication Related Osteonecrosis of the Jaws is Similar in Male and Female Mice.
    Hadaya D; Soundia A; Bezouglaia O; Pirih F; Aghaloo TL; Tetradis S
    J Oral Maxillofac Surg; 2024 Sep; 82(9):1139-1146. PubMed ID: 38909629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
    Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
    PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C; Fontenele RC; Oliveira-Santos N; Nogueira-Reis F; Van den Wyngaert T; Jacobs R
    Osteoporos Int; 2024 Aug; 35(8):1431-1440. PubMed ID: 38767743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
    Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
    Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor Radiographic Findings in Patients With Medication-Related Osteonecrosis of the Jaw.
    Kajihara R; Kondo E; Fukuda H; Sakai H; Koike T; Kurita H
    J Oral Maxillofac Surg; 2024 Aug; 82(8):984-991. PubMed ID: 38750657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience.
    Chen S; Ren H; He Y; An J; Zhang Y
    J Oral Maxillofac Surg; 2021 Dec; 79(12):2472-2481. PubMed ID: 34481810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic bone loss in patients with bisphosphonate-associated osteonecrosis of the jaws: a case-control study.
    Walter C; Laux C; Sagheb K
    Clin Oral Investig; 2014; 18(2):385-90. PubMed ID: 23525860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
    Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
    Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
    Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
    Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-related osteonecrosis of the jaw in a patient with multiple myeloma: an unusual case with tumor in the surgical specimen.
    Ogawa R; Minami Y; Ono J; Kanri Y; Kobayashi E; Tanaka A; Okada Y; Ogura I
    Oral Radiol; 2022 Apr; 38(2):288-291. PubMed ID: 34387843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.